Back to Journals » Drug Design, Development and Therapy » Volume 13

Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report

Total article views   Abstract views HTML views PDF downloads Totals
4,520 Dovepress* 3,603 329+ 862 3,932
PubMed Central* 0 588 183 588
Totals 3,603 917 1,045 4,520
*Since 11 January 2019
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar